A- A A+

Chien-Wei Su (蘇建維)

Chien-Wei Su(蘇建維)

簡介

學歷
  1. 國立陽明大學 臨床醫學研究所 博士
  2. 國立陽明大學 醫學系 醫學士
經歷 現職:
  1. - 迄今 台北榮民總醫院 胃腸肝膽科 主治醫師
  2. - 迄今 國立陽明大學 醫學系 副教授
  3. - 迄今 臺北榮民總醫院 內科部專責主治醫師病房 病房主任
  4. - 迄今 中華醫學會 副秘書長
  5. - 迄今 臺灣肝癌醫學會 理事
經歷:
  1. - 羅東博愛醫院 胃腸內科 主治醫師
  2. - 臺北榮民總醫院 胃腸科 總醫師
  3. - 臺北榮民總醫院 內科部 住院醫師
  4. - 蘇澳榮民醫院 內科 住院醫師
醫療專長
  1. 病毒性肝炎,肝癌之診斷與治療,腹部超音波診斷及治療
證照
  1. 內科醫學會
  2. 消化系醫學會
  3. 消化系內視鏡醫學會
  4. 肝癌專科醫師
  5. 整合醫學醫學會
  6. 臺灣內科醫學會
  7. 臺灣消化系醫學會
  8. 臺灣消化系超音波醫學會
  9. 中華民國醫用超音波醫學會
  10. 臺灣靜脈及腸道營養醫學會
  11. 臺灣肝臟研究學會
  12. 臺灣肝癌醫學會
  13. 美國肝病研究學會
  14. 歐洲肝臟研究學會
  15. 亞太肝臟研究學會
  16. 世界肝癌醫學會
語言專長
  1. 國語
  2. 英語
  3. 台語

著作

  1. Su CW, Huang YH, Huo TI, Shih HH, Sheen IJ, Chen SW, Lee PC, Lee SD, Wu JC. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology 2006;130:1625-1635. (SCI, IF: 17.373)
  2. Su CW, Hung HH, Huo TI, Huang YH, Li CP, Lin HC, Lee PC, Lee SD, Wu JC. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: A follow-up study up to 18 years. Liver Int 2008;28:1305-1313 (SCI, IF: 5.175)
  3. Hung HH, Su CW, Lai CR, Chau GY, Chan CC, Huang YH, Huo TI, Lee PC, Kao WY, Lee SD, Wu JC. Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis-B related hepatocellular carcinoma. Hepatol Int 2010;4:691-699 (SCI, IF: 5.102) (The first two authors [Hung HH and Su CW] have contributed equally to this work)
  4. Hung HH, Chiou YY, Hsia CY, Su CW (corresponding author), Chou YH, Chiang JH, Huo TI, Huang YH, Su YH, Lin HC, Lee SD, Wu JC. Survival rates are comparable following radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol 2011;9:79-86 (SCI, IF: 8.549)
  5. Su CW, Lei HJ, Chau GY, Hung HH, Wu JC, Hsia CY, Lui WY, Su YH, Wu CW, Lee SD. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: A propensity score matching analysis. Arch Surg 2012; 147:137-144 (SCI, IF: 13.625) (Journal title changed to JAMA Surg since 2013)
  6. Kao WY, Hwang CY, Chang YT, Su CW (corresponding author), Hou MC, Lin HC, Lee FY, Lee SD, Wu JC. Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study. Aliment Pharmacol Ther 2012; 36:467-476 (SCI, IF: 7.515)
  7. Wu WC, Wu CY, Wang YJ, Hung HH, Yang HI, Kao WY, Su CW (corresponding author), Wu JC, Chan WL, Lin HC, Lee FY, Lee SD. Updated threshold for serum alanine aminotransferase level in a large-scale population study composed of 34346 subjects. Aliment Pharmacol Ther 2012;36:560-568 (SCI, IF: 7.515)
  8. Fang KC, Su CW, Chiou YY, Lee PC, Chiu NC, Liu CA, Chen PH, Kao WY, Huang YH, Huo TI, Hou MC, Lin HC, Wu JC. The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation. Eur Radiol 2017;27:2600-2609 (SCI, IF: 4.101) (The first two authors [Fang KC and Su CW] have contributed equally to this work)
  9. Kao WY, Su CW, Chiou YY, Chiu NC, Liu CA, Fang KC, Huo TI, Huang YH, Chang CC, Hou MC, Lin HC, Wu JC. Hepatocellular carcinoma: Nomograms based on the albumin-bilirubin grade to assess the outcomes of radiofrequency ablation. Radiology 2017;285:670-680 (SCI, IF: 7.931) (The first two authors [Kao WY and Su CW] have contributed equally to this work)
  10. Su CW, Yang YY, Lin HC. Impact of etiological treatment on prognosis. Hepatol Int 2018;12 (Suppl 1):56-67 (SCI, IF: 5.102)
  11. Chen PH, Hsieh WY, Su CW*(corresponding author), Hou MC*, Wang YP, Hsin IF, Yang TC, Liao WC, Lin HC, Lee FY, Wu JC. Combination of albumin-bilirubin grade and platelet to predict compensated patient with hepatocellular carcinoma who do not require endoscopic screening for esophageal varices. Gastrointest Endosc 2018:88:230-9 (SCI, IF: 6.890)
  12. Fang KC, Kao WY, Su CW*(corresponding author), Chen PC, Lee PC, Huang YH, Huo TI, Chang CC, Hou MC, Lin HC, Wu JC*. The prognosis of single large hepatocellular carcinoma was distinct from the BCLC stage A or B: The role of albumin-bilirubin grade. Liver Cancer 2018;7:335-58 (SCI, IF: 9.720)
  13. Kao WY, Su CW*(corresponding author), Tan ECH*, Lee PC, Chen PH, Tang JH, Huang YH, Huo TI, Chang CC, Hou MC, Lin HC, Wu JC. Proton pump inhibitors and risk of hepatocellular carcinoma in patients with chronic hepatitis B or C. Hepatology 2019;69:1151-64 (SCI, IF: 14.679)